Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
Hupperts R, Becker V, Friedrich J, Gobbi C, Salgado A V, Sperling B, You X
Expert Opin Drug Deliv. 2014 Nov 28:1-11. Epub 1969 Dec 31. PMID: 25430947.Abstract